NEW YORK (GenomeWeb News) — Becton Dickinson today said that fiscal second-quarter revenues rose 11 percent as R&D spending decreased 32 percent and profit swelled 57 percent.
 
Total receipts for the three months ended March 31 increased to $1.6 billion from $1.4 billion year over year.
 
BD said revenues from its Diagnostics segment increased 11 percent to $473 million, while Biosciences revenue rose 13 percent to $258.5 million. Revenue from the Medical segment rose 10 percent to $844.1 million.  

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.